Moderna (MRNA) Q4 2024 Earnings Call Transcript
Moderna ( NASDAQ: MRNA) Q4 2024 Earnings Conference Call February 14, 2025 8:00 AM ET Lavina Talukdar - Senior Vice President, Investor Relations Stephane Bancel - Chief Executive Officer Jamey Mock - Chief Financial Officer Stephen Hoge - President
Manufacturing (AXL) reported its fourth-quarter 2024 earnings, revealing a narrower-than-expected loss and a notable surge in stock price. The company posted an adjusted EPS of -$0.06, surpassing the ...
Shares of the crypto exchange fell slightly to $295.18 each in pre-market trading on Friday, despite a better-than-expected ...
And thank you all for joining us at our Q4 and 12 months 2024 Conference Call. I’m Harry Vafias, the CEO of Imperial Petroleum; and joining us today is Fenia Sakellari who will be discussing our ...
Today, Arm Holdings will report its earnings for the third quarter of its 2025 financial year. Afterwards, the company will ...
RXO, which now has a full handle on the Coyote Logistics integration, was anticipated to keep its streak of decent quarters ...
Mamaearth's parent company, Honasa looks to mint Rs 4,000 crores revenue by 2030 with plans to boost its quick commerce ...
Take-Two Interactive’s Q3 2025 earnings call will take place today at 1:30 p.m. PT/4:30 p.m. ET. We’ll be streaming it on the ...
Moderna ( MRNA) reported mixed fourth quarter earnings, and full year 2024 earnings compared to Wall Street expectations Friday. Moderna's stock was down 4.5% in pre-market trading on the earnings ...
Tenet Healthcare beat on earnings but landed well short on revenue expectations for the fourth quarter of 2024, fueling a ...
Good morning, and welcome to the Conference Call for Tate & Lyle's Q3 Trading Statement. Your speakers today are Nick Hampton, Chief Executive; and Sarah Kuijlaars, Chief Financial Officer. I will now ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback